Editors' ChoiceAssociate Scientific Advisory Board

Expert Network

See allHide authors and affiliations

Science Translational Medicine  02 Mar 2011:
Vol. 3, Issue 72, pp. 72ec25
DOI: 10.1126/scitranslmed.3002327

Read, read, read. Read everything … Read! … You'll absorb it … If it is good, you'll find out.

–Novelist William Faulkner (1897–1962)

For a scientist, reading everything is an unrealistic goal, but reading widely is essential, particularly in interdisciplinary endeavors such as translational medicine. For a journal whose mission is to feature the best translational science on a wide range of subjects and make it accessible to a broad audience, creative measures—and people—are crucial.

Science Translational Medicine is pleased to introduce 16 of our secret weapons—our 2011 Associate Scientific Advisors (http://stm.sciencemag.org/site/about/assoc_advisors.xhtml). Each week, a subset of this talented group of variously trained early-career translational scientists will scan a bevy of scientific journals and select and summarize research papers for our Editors’ Choice section. Written in an informal and lively style, Editors’ Choice pieces can be easily absorbed by readers who are uninitiated in the subject matter. Each Associate Scientific Advisor will publish 10 to 12 Editors’ Choice articles in Science Translational Medicine over the coming year.

This collection of advisors was assembled, through a multistep selection process, from institutions that have received Clinical and Translational Science Awards (CTSAs) from the U.S. National Institutes of Health. With the help of Cynthia Morris of the Oregon Health & Science University and Frederick J. Meyers of the University of California, Davis, Science Translational Medicine asked principal investigators and mentors at CTSA institutions to nominate outstanding early-career translational scientists (M.D. and/or Ph.D.) to serve for a period of one year as Associate Scientific Advisors. From these nominees, the journal’s editors chose the Associate Scientific Advisory Board members through a process that included paper-selection and article-writing assignments. With this program, Science Translational Medicine is building connections with the community of trainees in translational medicine and providing them with opportunities for critical evaluation of the literature and scientific communication early in their careers.

This is the second year that Science Translational Medicine is sponsoring an Associate Scientific Advisors program. To see the collection of Editors’ Choice articles written by our 2010 team, go to the Science Translational Medicine search page (http://stm.sciencemag.org/search), click the Editors’ Choice box at the bottom of the page, and then click Search. For contributions from our new Advisors, stay tuned for articles on topics that range from neurobiology to nanodiamonds, cancer and cardiovascular disease to clinical trials, personalized medicine to policy. Although not even Faulkner fans will read everything, we hope our audience will sample selections from this growing trove of easily digestible morsels of translational science.

[2011 Associate Scientific Advisors]

Navigate This Article